Facet Biotech of Redwood City notified the SEC Tuesday that one of its shareholders, Roderick Wong, who controls some 124,828 shares, plans to offer five of his own nominees to be elected to the company’s board of directors, including himself.
The company said that its board and management, “are committed to Read the rest of this entry »
PDL Biopharma, the Redwood City biotechnology company that has been struggling to satisfy disgruntled shareholders by selling off assets and laying off workers for more than a year, said in an SEC filing Monday that royalty payments it had expected to start receiving before the end of its current quarter, won’t be coming any time soon.
In its quarterly financial statement filed in August, PDL had said it expected to start receiving royalty revenues Read the rest of this entry »
The board at PDL Biopharma, which has sold more than a half billion dollars’ worth of assets to assuage disgruntled investors, has decided to spread some of the cash around. On Friday, the company reported that non-employee directors would get a raise to better compensate for their ongoing efforts “to sell or otherwise monetize” the company’s assets,” including a possible spin-off of some of PDL’s product lines into a separate public company, according to an SEC filing Friday.
Non-employee directors will get an additional Read the rest of this entry »
Subscribe via RSS all feeds